Diluting Methadone To Liquid Form – Practice, Negative Impact, Diversion

The dilution of methadone with water was initiated as a result of the first federal methadone regulations because it was believed that this policy would reduce the diversion of methadone. While initially this policy may have had an impact within a short time most prospective buyers learning that methadone was now diluted with water and how to measure the amount of drug. Therefore diluting methadone with another solution usually sterile water has had a minimal impact on methadone diversion while creating other consequences that were not anticipated.

Comments on Methadone Diversion

Concern or rather the over-concern about methadone diversion has created a number of policies that programs and patients must adhere to while doing very little to reduce diversion. First it must be emphasized that the great majority of methadone patients take their medication as prescribed and do not sell or give it to anyone else. Therefore these policies have had a far-reaching impact on patients that are compliant.

System proposes that if diversion is of such concern to the federal and state agencies that “real efforts” be made to make methadone available to everyone that needs it. Studies have demonstrated that diverted methadone is typically purchased by addicts who are not able to get into treatment for whatever reason (i.e. wait lists, documentation, cost, program policy, believe methadone myths) (John Galea, Street Research Unit, OASAS, personal communication 2003). Instead of creating policies that make program policies more rigid and controlling and thus less attractive to prospective patients efforts should be focused on how to make treatment available to everyone that needs it. With the majority of dependent opioid addicts in methadone treatment the need for illicit methadone would cease. In countries where citizens have a right to medical and health care and methadone treatment is integrated into the medical system illicit methadone does not exist. It makes no sense for an addict to pay for something that is free and easily available (M. Reisinger, personal communication, 2002).

Methadone Dilution – Negative Impact

The dilution of methadone has a negative psychological impact on methadone patients and therefore results in a policy that is anti-therapeutic. No other medication is diluted in such a manner. Every time that a patient gets their medication — that is often diluted in front of them — a message is communicated to them that they are different than other medical patients and untrustworthy. Thus the program is forced to participate in a procedure that contributes to the low self-esteem of methadone patients. Former addicts may also harbor anxieties about their medication being diluted without their permission or that someone is diverting it from the clinic because they were subjected to practices like this (A Byrne, personal conversation, 2002).

Having one’s methadone dispensed in a pure form is reassuring to the patient that they are being treated like any other medical patient. Programs must come to realize that for methadone patients it is utmost importance that they be treated like any other medical patient. Diluting methadone has the potential to induce or worsen anxieties and even minor symptoms could be thought by the patient to be due to drug effects. Thus the treatment program has become the vehicle that promotes the same anxieties that the patient underwent while on the street.

Diluting methadone also has an impact that is rarely discussed because of the ramifications. Particularly when methadone is diluted and bottled prior to the patients coming to the clinic there is greater possibility of it being diverted by clinic staff. While such instances are rare they do occur as noted in a New York Times article in which a pharmacist was siphoning off the drugs he prepared for financial reasons (11/18/01). Almost every patient in methadone treatment has at least thought about this and the possibility that nursing or pharmacy staffs were diluting their methadone. System receives about eight complaints a year from patients suspicious about their medication. Since System has no investigative unit it is difficult to confirm how often these instances are occurring. However, the number of complaints indicates that a problem exists and that administering methadone in its standard form reduces suspicion and is reassuring for patients that they are treated like other medical patients.

Conclusion

Therefore System encourages programs to re-think their policy of diluting methadone. It is harmful to the psychic health of their patients who are constantly suspicious of the program and motives of the staff. Ending theses policies can only help to improve the therapeutic alliance that is necessary between patients and programs and improve the quality of treatment. It will also work towards reducing the stigma and elevate methadone treatment and the professionals working in it to their rightful place as a legitimate medical procedure.

References

New York Times, November 18, 2001. Prosecutors Say Greed Drove Pharmacist to Dilute Drugs, page 1.

 

[Download PDF] 

[Next Policy Statement]

[Index Policy Statements]

Similar Posts

  • Presidential Notes

    Admin 03/17/2022

    Stan Novick Stigma (STIG-ma): noun {From the Latin for “mark” or “brand”} a scar left by a hot iron a mark of shame or discredit an identifying mark or characteristic, i.e.: a specific diagnostic sign of a disease Everyone touched positively by methadone maintenance treatment is familiar with stigmatization. Patients, family members, friends, staff- we…

  • National Alliance for Medication Assisted Recover 435 Second Avenue New York, NY 10010      

    Admin 03/29/2022

    Membership Application Name:   _______________________________________________________   Mr. ___  Ms. ___  Dr. ___ Organization:  __________________________________________________________________________ Title:  _____________________________________________  Degree(s):  ________________________ Address:  _____________________________________________________________________________ Address:  _____________________________________________________________________________ City:   __________________________________   State:   ____________   Postal Code:   _____________ Email:  ______________________________________  Country:   ________________________________ Home Phone: (____)___________________________   Work Phone:  (____)_______________________ Alternate Phone:  (____)________________________   Fax:  (____)______________________________ If you have email may we send you bulletin alerts electronically. (This will get bulletin alerts to you quicker than usual mail)   Yes  _____   No _____ Types of Membership $_______ Individual Membership   Dues: $25 a…

  • In Memory of Ira Sobel

    Admin 03/26/2022

    New York City Many of you may not know who Ira was but to those who knew him from his writings and articles that appeared in many of our affiliates newsletters he was special. In many ways he was the typical patient who had been “hood winked” by the misinformation and negative barrage about methadone….

  • CERTIFIED METHADONE ADVOCATE (CMA)-1

    Admin 02/22/2023

    The Advocacy Training Session The training for certification includes a variety of topics to give advocates a well-grounded understanding of methadone treatment, research, regulations and laws that protect methadone patients and programs. Addiction and Methadone The biological constructs of addiction will be explained in a way that can be understood by lay people (i.e. opiate receptors,…

  • Next Training

    Admin 01/14/2022

    Training Schedule Certified MAT Advocate Training at the AATOD 2021 Conference . When: Saturday, April 10, 2021 Starts: 9 AM Where: The AATOD Conference will be virtual (Webinar) Register and Pay (Note: Regisration and Payment is through the Georgia Board.) Go Here Download Materials Training Materials For information about the conference visit the AATOD Conference…

  • About Webring

    Admin 06/30/2021

    Conference 2000 American Methadone Treatment Association April 9-12, 2000 San Francisco Committee Chair John Finger Assistant to the Chair, Michael Garrett Co-chair, Alice Diorio Committee James DePasquale Becky Duarte Barbara Finger Carlos Franco Greg Keller Howard Lotsof Judith Ostergard Carmen Pearman Diane Seaman Joycelyn Woods NAMA Events and Activities Exhibition Booth Booth Manager: Greg Keller,…